Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Net Cash Flow: 2014-2024

Historic Net Cash Flow for AC Immune (ACIU) over the last 11 years, with Dec 2024 value amounting to -$46.3 million.

  • AC Immune's Net Cash Flow rose 50.74% to -$9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.6 million, marking a year-over-year decrease of 410.58%. This contributed to the annual value of -$46.3 million for FY2024, which is 185.46% down from last year.
  • AC Immune's Net Cash Flow amounted to -$46.3 million in FY2024, which was down 185.46% from $54.2 million recorded in FY2023.
  • AC Immune's Net Cash Flow's 5-year high stood at $54.2 million during FY2023, with a 5-year trough of -$86.0 million in FY2021.
  • Moreover, its 3-year median value for Net Cash Flow was -$46.3 million (2024), whereas its average is -$15.1 million.
  • In the last 5 years, AC Immune's Net Cash Flow tumbled by 192.27% in 2020 and then surged by 202.06% in 2023.
  • AC Immune's Net Cash Flow (Yearly) stood at -$35.4 million in 2020, then plummeted by 143.09% to -$86.0 million in 2021, then soared by 38.28% to -$53.1 million in 2022, then spiked by 202.06% to $54.2 million in 2023, then slumped by 185.46% to -$46.3 million in 2024.